CorMedix Inc CRMD

7.85 0.08 1.03% as of 25 Sep
Market cap
$608.0M
P/E
3.3×
Insider Buys alert about insiders buying in the last 12 month
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
5.26 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
2.69 10.96 — 2,574.09 897.28 887.19 620.64 267.37 88.72 289.71
P/FCF ratio
4.85 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
8.87 (84.93) — (27.35) (29.20) (35.77) (45.26) (15.96) (4.02) (9.99)
P/B ratio
2.07 5.63 — 3.06 2.73 4.80 7.44 23.29 4.06 3.64
Price to Tangible BV
0.00 5.76 — 3.06 2.73 4.80 7.44 23.29 4.06 3.64
EV/Sales
2.68 9.79 — 1,683.43 558.04 696.40 519.95 240.22 51.82 198.96
EV/EBITDA
5.04 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
4.76 (8.41) — (4.52) (5.04) (7.58) (9.79) (4.36) (0.60) (2.00)
EV/FCF
4.83 (8.39) — (4.48) (4.72) (7.54) (9.76) (4.35) (0.59) (2.00)
Quick Ratio
1.83 3.05 6.68 9.34 12.28 11.19 4.90 2.29 1.95 4.97
Current Ratio
2.11 3.39 6.97 9.44 12.44 11.58 5.04 2.40 2.12 5.34
Net Debt/EBITDA
(0.02) 2.36 1.56 1.92 2.21 1.69 1.38 0.44 0.37 0.82
Debt/Assets
17.58% 0.00% 0.00% 1.08% 1.16% 1.87% 0.01% 32.54% 0.00% 0.00%
Debt/Equity
0.36 0.00 0.00 0.01 0.01 0.02 0.00 1.24 0.00 0.00
Asset Turnover
0.66 0.43 0.00 0.00 0.00 0.01 0.01 0.03 0.02 0.01
Operating CF/Net income
1.07 2.82 0.83 0.82 0.75 1.00 0.35 0.88 0.87 0.90
Capex/Depreciation
(0.15) (0.25) (1.59) (1.05) (8.05) (0.69) (0.09) (0.66) (4.12) (2.29)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
66.56% (23.17%) (74.02%) (50.40%) (52.72%) (64.91%) (304.66%) (442.49%) (264.01%) (95.10%)
ROA
34.51% (17.85%) (64.32%) (45.35%) (47.71%) (55.92%) (180.27%) (166.23%) (186.71%) (83.53%)
ROIC
23.34% (42.38%) 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
82.04% (21.72%) (66.28%) (54.15%) (45.07%) (49.91%) (184.13%) (242.59%) (458.89%) (138.37%)
Average Days of Receivables
200.51 433.70 — 0.00 86.80 5.19 0.00 9.26 71.05 19.54
Research and Development Expense of Revenue
6.20% 9.07% 0.00% 16,329.66% 6,879.52% 5,592.47% 3,901.48% 4,379.36% 7,435.80% 7,021.55%
Selling, General and Administrative Expense of Revenue
34.09% 135.02% 0.00% 30,590.37% 8,562.91% 5,801.80% 3,482.17% 1,878.71% 2,627.51% 3,963.90%
Intangible Assets out of Total Assets
0.50 0.02 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
4.44% 14.10% 0.00% 6,222.48% 2,641.49% 1,045.07% 861.14% 258.40% 503.83% 595.81%
Graham Net Nets
(0.06) 0.17 — 0.31 0.35 0.20 0.13 0.04 0.24 0.27
Graham Number
16.73 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
19.00% (4.07%) — (17.70%) (16.26%) (10.23%) (9.33%) (25.58%) (115.09%) (37.43%)
Free Cash Flow Yield
20.62% (10.64%) — (14.60%) (13.18%) (10.40%) (8.58%) (20.67%) (98.34%) (34.39%)
Revenue per Share
4.33 0.74 0.00 0.00 0.01 0.01 0.01 0.02 0.03 0.03
Operating CF per Share
2.43 (0.86) (0.75) (0.60) (0.56) (0.77) (0.62) (1.33) (2.59) (2.93)
Capex per Share
(0.03) 0.00 (0.01) (0.01) (0.04) 0.00 0.00 0.00 (0.01) (0.01)
Free Cash Flow per Share
2.40 (0.86) (0.76) (0.61) (0.60) (0.77) (0.62) (1.33) (2.61) (2.94)
Cash per Share
2.06 0.88 1.50 1.46 1.74 1.63 1.18 1.00 1.10 2.68
Shareholders Equity per Share
5.63 1.44 1.38 1.37 1.67 1.55 0.98 0.28 0.65 2.35
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
5.63 1.44 1.38 1.37 1.67 1.55 0.98 0.28 0.65 2.35
Free Cash Flow
172.79 (50.73) (38.74) (24.58) (22.58) (22.08) (15.09) (23.75) (28.74) (22.32)
Working Capital
192.78 80.74 68.05 53.24 61.12 44.02 23.52 10.90 7.01 17.74
Capital Expenditures
(2.26) (0.12) (0.33) (0.22) (1.43) (0.11) (0.04) (0.05) (0.15) (0.06)
Net Current Asset Value
(53.78) 80.39 67.53 52.57 60.32 43.10 23.52 4.77 7.01 17.74
EV/EBIT
5.55 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.01 0.00 0.00 3.35 7.47 0.47 0.13 0.11 0.46 0.26
Net Profit Margin
52.31% (41.24%) 0.00% (45,415.44%) (14,777.48%) (9,208.90%) (15,367.35%) (6,242.35%) (10,024.26%) (10,996.70%)
Price to Operating Income
5.58 0.00 — 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
2.58 0.25 0.11 0.13 0.12 1.46 3.16 0.46 0.20 0.37
Cash ROIC
24.19% (38.46%) (27.54%) (22.65%) (17.52%) (24.08%) (29.08%) (82.69%) (148.71%) (58.54%)
Accounts Receivable Turnover
2.80 1.68 — 0.00 7.82 140.71 51.98 11.46 8.65 1.37
Accounts Payable Turnover
7.49 1.06 0.00 0.00 0.09 0.19 0.21 0.18 0.07 0.22
Inventory Turnover
1.93 0.66 0.00 0.00 2.03 0.85 0.97 0.78 0.30 1.35
Average Days of Payables
80.02 196.80 0.00 217,234.19 5,416.41 2,010.53 1,001.79 2,381.51 5,739.39 1,637.67
Days of Inventory on Hand
301.61 869.59 0.00 0.00 7.35 255.93 331.06 394.16 1,885.94 165.93
Average Receivables
111.44 25.85 — — 0.02 0.00 0.01 0.04 0.04 0.16
Average Payables
4.80 3.00 3.24 2.21 1.67 1.08 1.81 2.20 1.73 1.68
Average Inventory
18.66 4.85 1.05 — 0.07 0.24 0.38 0.51 0.38 0.27
Average Assets
472.49 100.45 72.05 65.49 59.13 39.39 24.15 16.14 17.68 29.50
Average Common Equity
244.98 77.40 62.60 58.93 53.51 33.93 14.29 6.06 12.50 25.91

Fold the line items

Columns are period end dates